- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01795469
Abdominal and Lower Extremity Compression During Tilt Table Testing in Adolescent POTS Patients
January 28, 2017 updated by: Geoffrey Heyer, Nationwide Children's Hospital
Postural orthostatic tachycardia syndrome (POTS) is a common cause of orthostatic intolerance in adolescents and adults.
Compression stockings are commonly recommended as a treatment modality for POTS, but the effects of abdominal and lower extremity compression during tilt table testing have not been measured in adolescent patients.
The aims of our study are to compare heart-rate changes and symptom onset during tilt table testing (a) with and without abdomen/lower extremity compression and (b) with abdominal compression only versus lower extremity compression only.
During phase 1, 20 adolescents with POTS will undergo up to 10 minutes of tilt without compression (trial #1), a repeat study of up to 10 minutes with full compression (trial #2), and a third study without compression up to 10 minutes (trial #3).
Compression will be performed using the non-inflatable Zoex anti-shock garment.
During study phase 2, an additional 20 adolescent POTS patients will undergo up to 10 minutes of tilt without compression (trial #1), a repeat study of up to 10 minutes with abdominal compression only [n=10] or lower extremity compression only [n=10] (trial #2), and a third study repeated without compression up to 10 minutes (trial #3).
To limit compression to the abdomen only, we will use the Zoex garment strap numbers 4 and 5 (thigh and abdomen) without straps 1-3 (lower extremities).
For lower extremity-only compression, we will use Zoex garment straps 1-4 (lower extremity and thigh) without strap 5. Data collected will include mean and peak heart rates and timing of symptoms with each trial.
A paired-samples t-test will be used to compare mean heart rates between trials for each study phase.
Hazard analyses will be used to assess time-based endpoints.
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ohio
-
Columbus, Ohio, United States, 43205
- Nationwide Children's Hospital, neurology outpatient clinic
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
8 years to 15 years (Child, Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 12-19 years
- POTS diagnosis
- English speaking -
Exclusion Criteria:
- Somatic, cognitive, or psychiatric disorder that could prevent safe tilt table testing
- Medications that cannot be stopped/held safely for the procedure, but can cause or exacerbate orthostatic intolerance -
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Abdominal and LE compression
Zoex compression garment during tilt testing (all straps)
|
5-strap compression of abdomen, thighs and legs
|
|
Experimental: abdominal compression only
Zoex compression garment use during tilt table testing (straps 4 and 5 fastened around thighs and abdomen)
|
5-strap compression of abdomen, thighs and legs
|
|
Experimental: Lower extremity compression only
Zoex compression garment use during tilt table testing (straps 1-4, lower extremity and thighs, fastened)
|
5-strap compression of abdomen, thighs and legs
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Heart-rate elevation
Time Frame: Comparison between tilt table trials of up to 10 minutes duration without and with abdominal and/or lower extremity compression
|
Comparison between tilt table trials of up to 10 minutes duration without and with abdominal and/or lower extremity compression
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Symptom onset
Time Frame: Comparison between tilt table trials of up to 10 minutes duration witout and with abdominal and/or lower extremity compression
|
Comparison between tilt table trials of up to 10 minutes duration witout and with abdominal and/or lower extremity compression
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2013
Primary Completion (Actual)
February 1, 2016
Study Completion (Actual)
February 1, 2016
Study Registration Dates
First Submitted
February 18, 2013
First Submitted That Met QC Criteria
February 18, 2013
First Posted (Estimate)
February 20, 2013
Study Record Updates
Last Update Posted (Estimate)
January 31, 2017
Last Update Submitted That Met QC Criteria
January 28, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Heart Diseases
- Cardiovascular Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Neurobehavioral Manifestations
- Arrhythmias, Cardiac
- Cardiac Conduction System Disease
- Autonomic Nervous System Diseases
- Unconsciousness
- Consciousness Disorders
- Primary Dysautonomias
- Orthostatic Intolerance
- Tachycardia
- Syncope
- Postural Orthostatic Tachycardia Syndrome
Other Study ID Numbers
- IRB13-00033 (NCH IRB number)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Syncope
-
David B. De LurgioBiosense Webster, Inc.CompletedNeurocardiogenic Syncope | Vasovagal SyncopeUnited States
-
Tanvir HospitalEnrolling by invitationVasovagal Syncope (VVS)India
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
-
University of CalgaryRecruitingSyncope | Vasovagal Syncope (VVS)Canada
-
University of CalgaryRecruiting
-
Centre of Postgraduate Medical EducationTerminated
-
Dr. Bob SheldonVanderbilt UniversityActive, not recruitingVasovagal SyncopeUnited States, Canada, Poland
-
University of CalgaryCardiac Arrhythmia Network of CanadaCompleted
-
Gruppo Italiano Multidisciplinare per lo Studio...Completed
Clinical Trials on Zoex compression garment
-
University Hospital Schleswig-HolsteinCompleted
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHemorrhage | Hypovolemic ShockZambia, Zimbabwe
-
University of Colorado, DenverNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)Recruiting
-
Isabel Forner-Cordero, MD, PhDHospital Arnau de Vilanova; Hospital Provincial de CastellonRecruiting
-
University of California, San FranciscoMacArthur FoundationCompletedHemorrhage | Hypovolemic ShockEgypt
-
University of Colorado, DenverColorado Joint Replacement; mediCompleted
-
Hôpital Raymond PoincaréUnknownHypermobility Type Ehlers-Danlos SyndromeFrance
-
University of OklahomaTerminated
-
University of CalgaryCompleted
-
Violeta Pajero OteroHospital Universitario 12 de Octubre; University of Castilla-La ManchaCompletedBreast Cancer LymphedemaSpain